Cold Plasma Market Synopsis

Cold Plasma Market Size Was Valued at USD 2228.21 Million in 2023 and is Projected to Reach USD 7962.11 Million by 2032, Growing at a CAGR of 15.2% From 2024-2032.

Cold plasma is a partially ionized gas created at low temperatures and is considered the fourth state of matter. It contains a mix of positively and negatively charged particles, with unique properties useful in sterilization, wound healing, and air purification.

• Cold plasma can sterilize and disinfect surfaces by effectively eliminating bacteria and viruses. It accelerates the healing process by encouraging cells to move and regenerate tissue.
• Cold plasma alters the surfaces of materials to improve characteristics such as adhesion and biocompatibility. Cold plasma sterilizes food, increasing its longevity without leaving behind any chemical remnants.
• Plasma air purification technology is effective in eliminating contaminants to improve the quality of indoor air. In cancer treatment, it specifically attacks cancer cells without harming normal tissue.
• Dental uses encompass sterilization, treatment of gum disease, and whitening of teeth. Environmental applications involve breaking down pollutants in wastewater, eliminating VOCs from the air, and cutting back on greenhouse gas emissions.

Top Active Players Involved Are:

Nordson Corporation (U.S.), Europlasma NV (Belgium), Plasmatreat GmbH (Germany), Terraplasma Medical GmbH (Germany), Henniker Plasma (United Kingdom), US Medical Innovations (United States), Molecular Plasma Group (United States), Adtec Plasma Technology Co Ltd. (Japan), Smith & Nephew plc. (United Kingdom), Thierry Corporation (United States), AcXys Plasma Technologies (France), Apyx Medical (United States), Coating Plasma Innovation (France), Enercon Industries Corporation (United States), P2i Limited (United Kingdom), Neoplas GmbH (Germany), Softal Corona & Plasma GmbH (Germany), Surfx Technologies, LLC (United States), Tantec A/S (Denmark), Plasma Etch, Inc. (United States), 3M Company (United States), Coloplast A/S (Denmark), Baxter International Inc. (United States), Covidien PLC. (Medtronic plc.) (Ireland/United States), Ethicon, Inc. (Johnson & Johnson) (United States), and Other Active Players.

Cold Plasma Market Trend Analysis

Adoption by Food & Beverage Industry

• Cold plasma reliably inactivates bacteria and viruses, including the ones responsible for foodborne diseases. Safety and minimizing the risk of contamination are top priorities for the food industry. Cold plasma treatments offer a chemical-free, non-thermal alternative for disinfecting surfaces and equipment.
• Cold plasma treatment aids in prolonging the shelf life of perishable foods by diminishing microbial levels and preventing the growth of spoilage microorganisms. This helps maintain the freshness and quality of food.
• Cold plasma treatment changes the surface properties of packaging to increase its barrier function against oxygen, moisture, and contaminants, thereby enhancing performance, reducing spoilage, and prolonging shelf life.
• Cold plasma technology in the food and beverage sector is eco-friendly, utilizing low levels of chemicals and energy usage, supporting sustainability objectives in decreasing environmental harm and carbon emissions.

Opportunity

Cold Plasma Treatment for Chronic Wounds

• Cold plasma enhances the healing of chronic, treatment-resistant wounds by stimulating cellular activity, promoting angiogenesis, and modulating the wound environment to accelerate the healing process.
• Non-invasive cold plasma treatment is painless and ideal for chronic wound patients with low pain thresholds. Cold plasma treats chronic wounds like diabetic ulcers, pressure ulcers, venous leg ulcers, and non-healing surgical wounds, broadening market potential.
• Chronic wounds prone to infection. Cold plasma's antimicrobial properties reduce bacteria, prevent infection, and support a clean healing environment. Ongoing studies are increasing in the field of cold plasma treatment. Progress in plasma technology and treatment procedures enables creative improvements.

Cold Plasma Market Segment Analysis:

The cold Plasma market is segmented on the basis of Regime Type, Technology, Application, End-user.

By Regime Type, Low-pressure Segment Is Expected to Dominate the Market During the Forecast Period

There are two segments such as low-pressure and atmospheric pressure. Among these, the low-pressure segment is expected to dominate the market during the forecast period.

• Low-pressure cold plasma's precision and control make it desirable in healthcare, food, agriculture, textiles, and electronics, leading to high demand. Rising market for low-pressure plasma in India and China, fueled by industrialization, higher incomes, and manufacturing advancements, will drive growth.
• Low-pressure cold plasma is a popular option in medical industries for disinfecting equipment and treating wounds because it can effectively sterilize without causing harm to products.
• Low-pressure plasma is a safer option for human use compared to atmospheric-pressure plasma because it is more controllable and less hazardous. This feature makes it an attractive choice for medical and personal care items.
• Developments in low-pressure plasma technology provide effective and economical solutions, prompting companies and manufacturers to put money into this advanced technology.

By Application, Wound Healing Segment Held the Largest Share In 2023

There are five segments by application such as wound healing, cancer treatment, dentistry, wastewater treatment, and seed germination. Among these, the wound healing segment held the largest share in 2023.

• Cold plasma speeds up wound healing by enhancing cell movement, growth, and blood vessel formation. It triggers growth factor release and changes the wound environment, aiding tissue repair. Its benefits make it ideal for treating challenging wounds.
• Cold plasma, which has antimicrobial properties, fights infections in chronic wounds, promoting a sterile environment and accelerating the healing process. Avoids interruptions due to the multiplication of bacteria.
• Cold plasma wound healing is not invasive and is well tolerated, in contrast to traditional therapies that can cause discomfort or pain for patients. The diverse uses of cold plasma in healing diabetic ulcers, burns, surgical wounds, and pressure ulcers add value in various healthcare environments.
• Increasing numbers of chronic wounds highlight the necessity for successful healing remedies. Cold plasma holds potential for tackling the difficulties posed by diabetic ulcers and venous leg ulcers.

• This pie chart shows that cold plasma is mainly used in wound healing (40%) and followed by cancer treatment (25%).

Cold Plasma Market Regional Insights:

Asia Pacific is Expected to Dominate the Market Over the Forecast Period

• The rapid industrial growth in Asia Pacific, especially in China and India, drives production in industries such as electronics, automotive, healthcare, and textiles. The use of cold plasma is essential for tasks such as surface cleaning, activation, and modifying materials, making it popular in industries in the region.
• Cold plasma is becoming more and more common in the healthcare industry for treating wounds, battling cancer, and sterilizing equipment. The cold plasma market is experiencing growth due to the region's investments in healthcare and increased demand for advanced technologies.
• Asia Pacific, possessing the largest population globally, presents a substantial market for various industries. Increased population density results in health issues, which heighten the demand for advanced medical treatments such as cold plasma.
• In countries such as Japan, South Korea, and China in Asia Pacific, cold plasma technologies are quickly progressing with research institutions, universities, and companies actively participating, driving innovation, productivity, and investment across different sectors.

Cold Plasma Market Active Players

• Nordson Corporation (U.S.)
• Europlasma NV (Belgium)
• Plasmatreat GmbH (Germany)
• Terraplasma Medical GmbH (Germany)
• Henniker Plasma (United Kingdom)
• US Medical Innovations (United States)
• Molecular Plasma Group (United States)
• Adtec Plasma Technology Co Ltd. (Japan)
• Smith & Nephew plc. (United Kingdom)
• Thierry Corporation (United States)
• AcXys Plasma Technologies (France)
• Apyx Medical (United States)
• Coating Plasma Innovation (France)
• Enercon Industries Corporation (United States)
• P2i Limited (United Kingdom)
• Neoplas GmbH (Germany)
• Softal Corona & Plasma GmbH (Germany)
• Surfx Technologies, LLC (United States)
• Tantec A/S (Denmark)
• Plasma Etch, Inc. (United States)
• 3M Company (United States)
• Coloplast A/S (Denmark)
• Baxter International Inc. (United States)
• Covidien PLC. (Medtronic plc.) (Ireland/United States)
• Ethicon, Inc. (Johnson & Johnson) (United States), and Other Active Players.

Key Industry Developments in the Cold Plasma Market:

• In May 2024, Tianqi Zhang at the University of Sydney and one of the study’s scientists announced that for the first time, scientists have transformed the carbon in biogas into long-chain hydrocarbons using a cold plasma. Biogas, a mixture of carbon dioxide and methane, is produced when microorganisms decompose organic matter in the absence of oxygen. Although cold plasmas have been used to recycle carbon from biogas in the past, it was restricted to producing simple hydrocarbons.
• In July 2023, Science-driven skincare brand Perricone MD launched a Cold Plasma Plus+ Lip Therapy, adding to its multi-tasking Cold Plasma Plus+ collection. The new treatment features the brand's proprietary liquid crystal delivery system for faster and deeper penetration of key ingredients into the skin's surface. It also includes peptides, omega fatty acids, and hyaluronic acid.